NASDAQ
Gene Biotherapeutics, Inc. (CRXM) has a total debt of $1.26M as of Thursday, December 31, 2020. Total debt represents the sum of a company's short-term and long-term borrowings, indicating its overall leverage and financial obligations.
No price data available for this timeframe.